Anti-LAG3重组抗体|科研级 Ieramilimab (埃拉利单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-LAG3重组抗体|科研级 Ieramilimab (埃拉利单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-LAG3重组抗体|科研级 Ieramilimab (埃拉利单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1554

Alias

科研级 Ieramilimab (埃拉利单抗 ), Anti-LAG3 Recombinant Antibody, Research Grade Ieramilimab

Molecular Name

Ieramilimab

Size

1mg, 5mg

CAS Number

2137049-37-5

Isotype

IgG4 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

LAG3 [Homo sapiens]

Background

Ieramilimab (development code LAG525) is a monoclonal antibody being developed by Novartis for the treatment of cancer. The antibody targets the immune checkpoint LAG-3, which is expressed on T cells and tends to down-regulate an immune response. In a June 2015 presentation Novartis management indicated that 'dosing is imminent' for the first clinical trials of LAG525.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ